"Many of us at Merck Canada are thrilled with KEYTRUDA being offered in Canada to treat advanced melanoma, because it provides new therapy to patients facing this difficult-to-treat cancer," stated Chirfi Guindo, Md, Merck Canada Corporation. "This latest product embodies Merck’s unwavering dedication to be the main thing on scientific discovery and innovation to assist Canadian patients."
"The conditional approval of the cool product in Canada marks a brand new era in how advanced melanoma is going to be treated within this population having a high unmet medical need," stated Dr. Marcus Butler, Medical Oncologist at Princess Margaret Cancer Center, Director of Princess Margaret Immune Monitoring Laboratory. "For patients struggling with signs and symptoms of the advanced disease, the merchandise isn’t just effective, but additionally well-tolerated."
"We commend the choice to issue an NOC/c for KEYTRUDA in Canada for metastatic melanoma, the deadliest type of cancer of the skin," stated Kathy Barnard, Founding father of the Save Your Valuable Skin Foundation. "Like a survivor of advanced melanoma myself," she adds, "I understand first-hands what very good news to Canadians struggling with this deadly disease, who might well be from treatments. Immuno-oncology is a vital rise in cancer treatment."
"It’s difficult to contain my enthusiasm," added Annette Cyr, Chair and Founder, Melanoma Network of Canada. "This latest therapy leads us aspire to have regression from the disease, improved quality of existence and also the potential to possess a existence free from this aggressive cancer."
Keytruda approved for Lung Cancer Treatment
TheRealDadfad: They don't tell you the treatment costs about $12,000 per month.